Home-based technologies: A new paradigm for conducting dementia prevention trials

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The approach toward treatment of Alzheimer's disease has evolved out of a large body of research, resulting in a common trial paradigm directed toward establishing efficacy and safety of putative treatments for dementia. To achieve the ultimate goal of preventing dementia, the future will build on this model but will need to incorporate new paradigms to more efficiently detect meaningful change over time. Among new innovations needed is the capability for assessing trajectories of change over many years. Intrinsic to this success is the ability to capture increasing variability as well as subject heterogeneity inherent in longitudinal aging cohorts. New methods of ubiquitous embedded home sensing and computing afford the opportunity to assess volunteers not only during long periods of time but with greater frequency and convenience. Clinical studies identifying the optimal ways of using these methods are needed.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
Volume4
Issue number1 SUPPL. 1
DOIs
StatePublished - Jan 2008

Fingerprint

Dementia
Technology
Aptitude
Volunteers
Alzheimer Disease
Safety
Therapeutics
Research
Clinical Studies

Keywords

  • Activity assessment
  • Clinical trials
  • Cognitive assessment
  • Dementia
  • Mild cognitive impairment (MCI)
  • Sensors
  • Technology

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Home-based technologies : A new paradigm for conducting dementia prevention trials. / Kaye, Jeffrey.

In: Alzheimer's and Dementia, Vol. 4, No. 1 SUPPL. 1, 01.2008.

Research output: Contribution to journalArticle

@article{444ce6b03bf54fc38c4681a6a3243297,
title = "Home-based technologies: A new paradigm for conducting dementia prevention trials",
abstract = "The approach toward treatment of Alzheimer's disease has evolved out of a large body of research, resulting in a common trial paradigm directed toward establishing efficacy and safety of putative treatments for dementia. To achieve the ultimate goal of preventing dementia, the future will build on this model but will need to incorporate new paradigms to more efficiently detect meaningful change over time. Among new innovations needed is the capability for assessing trajectories of change over many years. Intrinsic to this success is the ability to capture increasing variability as well as subject heterogeneity inherent in longitudinal aging cohorts. New methods of ubiquitous embedded home sensing and computing afford the opportunity to assess volunteers not only during long periods of time but with greater frequency and convenience. Clinical studies identifying the optimal ways of using these methods are needed.",
keywords = "Activity assessment, Clinical trials, Cognitive assessment, Dementia, Mild cognitive impairment (MCI), Sensors, Technology",
author = "Jeffrey Kaye",
year = "2008",
month = "1",
doi = "10.1016/j.jalz.2007.10.003",
language = "English (US)",
volume = "4",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "1 SUPPL. 1",

}

TY - JOUR

T1 - Home-based technologies

T2 - A new paradigm for conducting dementia prevention trials

AU - Kaye, Jeffrey

PY - 2008/1

Y1 - 2008/1

N2 - The approach toward treatment of Alzheimer's disease has evolved out of a large body of research, resulting in a common trial paradigm directed toward establishing efficacy and safety of putative treatments for dementia. To achieve the ultimate goal of preventing dementia, the future will build on this model but will need to incorporate new paradigms to more efficiently detect meaningful change over time. Among new innovations needed is the capability for assessing trajectories of change over many years. Intrinsic to this success is the ability to capture increasing variability as well as subject heterogeneity inherent in longitudinal aging cohorts. New methods of ubiquitous embedded home sensing and computing afford the opportunity to assess volunteers not only during long periods of time but with greater frequency and convenience. Clinical studies identifying the optimal ways of using these methods are needed.

AB - The approach toward treatment of Alzheimer's disease has evolved out of a large body of research, resulting in a common trial paradigm directed toward establishing efficacy and safety of putative treatments for dementia. To achieve the ultimate goal of preventing dementia, the future will build on this model but will need to incorporate new paradigms to more efficiently detect meaningful change over time. Among new innovations needed is the capability for assessing trajectories of change over many years. Intrinsic to this success is the ability to capture increasing variability as well as subject heterogeneity inherent in longitudinal aging cohorts. New methods of ubiquitous embedded home sensing and computing afford the opportunity to assess volunteers not only during long periods of time but with greater frequency and convenience. Clinical studies identifying the optimal ways of using these methods are needed.

KW - Activity assessment

KW - Clinical trials

KW - Cognitive assessment

KW - Dementia

KW - Mild cognitive impairment (MCI)

KW - Sensors

KW - Technology

UR - http://www.scopus.com/inward/record.url?scp=38049050705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049050705&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2007.10.003

DO - 10.1016/j.jalz.2007.10.003

M3 - Article

C2 - 18632003

AN - SCOPUS:38049050705

VL - 4

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 1 SUPPL. 1

ER -